LONGITUDE: An observational study of the long-term effectiveness of elexacaftor/tezacaftor/ivacaftor in people aged ≥12 years with cystic fibrosis using data from the United Kingdom Cystic Fibrosis Registry - 2-year analysis
- DOI
- 10.1016/j.jcf.2025.04.012
- Published
- 2025-07
- Container
- Journal of Cystic Fibrosis
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.jcf.2025.04.012,
title = {LONGITUDE: An observational study of the long-term effectiveness of elexacaftor/tezacaftor/ivacaftor in people aged ≥12 years with cystic fibrosis using data from the United Kingdom Cystic Fibrosis Registry - 2-year analysis},
author = {Gabriela Vega-Hernandez and Gordon MacGregor and Andrew Wilfin and Francis Adams and Ciarán Haugh and Carl A. Baxter and Heike Wöhling and Sarah L. Clarke and Susan C. Charman and Siobhán B. Carr},
year = {2025},
journal = {Journal of Cystic Fibrosis},
doi = {10.1016/j.jcf.2025.04.012},
url = {https://doi.org/10.1016/j.jcf.2025.04.012}
}RIS
TY - JOUR TI - LONGITUDE: An observational study of the long-term effectiveness of elexacaftor/tezacaftor/ivacaftor in people aged ≥12 years with cystic fibrosis using data from the United Kingdom Cystic Fibrosis Registry - 2-year analysis AU - Gabriela Vega-Hernandez AU - Gordon MacGregor AU - Andrew Wilfin AU - Francis Adams AU - Ciarán Haugh AU - Carl A. Baxter AU - Heike Wöhling AU - Sarah L. Clarke AU - Susan C. Charman AU - Siobhán B. Carr PY - 2025 JO - Journal of Cystic Fibrosis DO - 10.1016/j.jcf.2025.04.012 UR - https://doi.org/10.1016/j.jcf.2025.04.012 ER -
APA
Vega-Hernandez, G., MacGregor, G., Wilfin, A., Adams, F., Haugh, C., Baxter, C. A., Wöhling, H., Clarke, S. L., Charman, S. C., & Carr, S. B. (2025). LONGITUDE: An observational study of the long-term effectiveness of elexacaftor/tezacaftor/ivacaftor in people aged ≥12 years with cystic fibrosis using data from the United Kingdom Cystic Fibrosis Registry - 2-year analysis. Journal of Cystic Fibrosis. https://doi.org/10.1016/j.jcf.2025.04.012
Source records
- crossref · retrieved 2026-09-26T22:34:54.398Z